RHYTHM PHARMACEUTICALS, INC. (RYTM) Operating Income (Loss) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$140 M, a 166% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$272 M, a 51.8% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$184 M, a 2.9% decline from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179 M, a 5.35% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$170 M, a 24.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$272 M -$140 M -$87.4 M -166% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$184 M -$41.3 M +$834 K +1.98% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$185 M -$44 M -$4.69 M -11.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$181 M -$46.6 M -$1.51 M -3.34% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$179 M -$52.5 M +$160 K +0.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$179 M -$42.1 M +$8.89 M +17.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$188 M -$39.3 M +$4.97 M +11.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$193 M -$45.1 M -$4.66 M -11.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$188 M -$52.7 M -$18.3 M -53.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$170 M -$51 M -$15.9 M -45.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$154 M -$44.2 M -$9.96 M -29% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$144 M -$40.4 M -$8.51 M -26.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$136 M -$34.4 M +$902 K +2.56% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$137 M -$35.1 M -$849 K -2.48% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$136 M -$34.3 M +$2.82 M +7.61% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$139 M -$31.9 M +$12.2 M +27.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$151 M -$35.3 M -$4.78 M -15.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 -$146 M -$34.2 M -$7.07 M -26.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$139 M -$37.1 M -$17.9 M -92.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$121 M -$44.1 M -$29.1 M -194% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 -$91.9 M -$30.5 M -$13.5 M -79.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$78.4 M -$27.2 M -$16.2 M -147% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$62.2 M -$19.2 M -$11 M -132% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$51.3 M -$15 M -$8.27 M -122% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 -$43 M -$17 M -$10.6 M -166% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 -$32.4 M -$11 M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$8.29 M -$1.89 M -29.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$6.75 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$6.39 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$6.4 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.